About Us

SUCCINATE AT A GLANCE

Specific succinate consuming bacteria is associated to high levels of circulating succinate

OUR STORY

SUCCIPRO is a spin-off company born from solid science on succinate pathophysiology from the DIAMET Research group (www.diamet,org), located at IISPV (www.IISPV.cat). SUCCIPRO is exclussively focused on succinate-modulating therapies.

OUR VISION

We are pioneers in the discovery and development of novel pharmaceuticals based on our unrivaled understanding of succinate biology and its role at the crossroad of inflammation and metabolism.

OUR TECHNOLOGY

We are using our knowledge, expertise and unique proprietary tools to generate a pipeline of pre-clinical candidates with a focus on inflammatory and metabolic diseases.